Sensitive ASX Announcement

Neuren opens first site in US for Prader-Willi Phase 2 trial

Published: 28/06/23, 09:55am (AEST)3 pages
Neuren Pharmaceuticals Limited
NEU:ASXHealthcare

Recent NEU Announcements

Price Sensitive only